139 related articles for article (PubMed ID: 19405081)
1. The anti-interleukin-1 in type 1 diabetes action trial--background and rationale.
Pickersgill LM; Mandrup-Poulsen TR
Diabetes Metab Res Rev; 2009 May; 25(4):321-4. PubMed ID: 19405081
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-1 receptor antagonist (IL-1Ra) and IL-1Ra producing mesenchymal stem cells as modulators of diabetogenesis.
Volarevic V; Al-Qahtani A; Arsenijevic N; Pajovic S; Lukic ML
Autoimmunity; 2010 Jun; 43(4):255-63. PubMed ID: 19845478
[TBL] [Abstract][Full Text] [Related]
3. New prospects for immunotherapy at diagnosis of type 1 diabetes.
Pozzilli P; Leslie RD
Diabetes Metab Res Rev; 2009 May; 25(4):299-301. PubMed ID: 19405079
[TBL] [Abstract][Full Text] [Related]
4. Immune-mediated beta-cell destruction in vitro and in vivo-A pivotal role for galectin-3.
Karlsen AE; Størling ZM; Sparre T; Larsen MR; Mahmood A; Størling J; Roepstorff P; Wrzesinski K; Larsen PM; Fey S; Nielsen K; Heding P; Ricordi C; Johannesen J; Kristiansen OP; Christensen UB; Kockum I; Luthman H; Nerup J; Pociot F
Biochem Biophys Res Commun; 2006 May; 344(1):406-15. PubMed ID: 16600178
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-1 beta induced transient diabetes mellitus in rats. A model of the initial events in the pathogenesis of insulin-dependent diabetes mellitus?
Reimers JI
Dan Med Bull; 1998 Apr; 45(2):157-80. PubMed ID: 9587701
[TBL] [Abstract][Full Text] [Related]
6. [Immunological intervention to preserve beta-cell function in type 1 diabetes].
Schloot NC
Dtsch Med Wochenschr; 2010 May; 135(18):915-21. PubMed ID: 20425677
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials.
Moran A; Bundy B; Becker DJ; DiMeglio LA; Gitelman SE; Goland R; Greenbaum CJ; Herold KC; Marks JB; Raskin P; Sanda S; Schatz D; Wherrett DK; Wilson DM; Krischer JP; Skyler JS; ; Pickersgill L; de Koning E; Ziegler AG; Böehm B; Badenhoop K; Schloot N; Bak JF; Pozzilli P; Mauricio D; Donath MY; Castaño L; Wägner A; Lervang HH; Perrild H; Mandrup-Poulsen T;
Lancet; 2013 Jun; 381(9881):1905-15. PubMed ID: 23562090
[TBL] [Abstract][Full Text] [Related]
8. [Recent advances in the treatment of type 1 diabetes mellitus].
Schloot NC; Roden M; Bornstein SR; Brendel MD
Dtsch Med Wochenschr; 2011 Feb; 136(5):172-5. PubMed ID: 21271474
[TBL] [Abstract][Full Text] [Related]
9. Therapy with GAD in diabetes.
Ludvigsson J
Diabetes Metab Res Rev; 2009 May; 25(4):307-15. PubMed ID: 19267332
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulation with heat shock protein DiaPep277 to preserve beta cell function in type 1 diabetes - an update.
Fischer B; Elias D; Bretzel RG; Linn T
Expert Opin Biol Ther; 2010 Feb; 10(2):265-72. PubMed ID: 20034363
[TBL] [Abstract][Full Text] [Related]
11. Essential role for signal transducer and activator of transcription-1 in pancreatic beta-cell death and autoimmune type 1 diabetes of nonobese diabetic mice.
Kim S; Kim HS; Chung KW; Oh SH; Yun JW; Im SH; Lee MK; Kim KW; Lee MS
Diabetes; 2007 Oct; 56(10):2561-8. PubMed ID: 17620422
[TBL] [Abstract][Full Text] [Related]
12. Anti-proliferative effect of pro-inflammatory cytokines in cultured beta cells is associated with extracellular signal-regulated kinase 1/2 pathway inhibition: protective role of glucagon-like peptide -1.
Blandino-Rosano M; Perez-Arana G; Mellado-Gil JM; Segundo C; Aguilar-Diosdado M
J Mol Endocrinol; 2008 Jul; 41(1):35-44. PubMed ID: 18487229
[TBL] [Abstract][Full Text] [Related]
13. [Targeted anti-cytokine therapies for osteoarthritis].
Chevalier X; Mugnier B; Bouvenot G
Bull Acad Natl Med; 2006 Oct; 190(7):1411-20; discussion 1420, 1475-7. PubMed ID: 17450677
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the age-at-onset heterogeneity in type 1 diabetes through mathematical modeling.
Wang X; He Z; Ghosh S
Math Biosci; 2006 Sep; 203(1):79-99. PubMed ID: 16723139
[TBL] [Abstract][Full Text] [Related]
15. S-methyl-L-thiocitrulline counteracts interleukin 1 beta induced suppression of pancreatic islet function in vitro, but does not protect against multiple low-dose streptozotocin-induced diabetes in vivo.
Sternesjö J; Welsh N; Sandler S
Cytokine; 1997 May; 9(5):352-9. PubMed ID: 9195135
[TBL] [Abstract][Full Text] [Related]
16. Transfusion of apoptotic beta-cells induces immune tolerance to beta-cell antigens and prevents type 1 diabetes in NOD mice.
Xia CQ; Peng R; Qiu Y; Annamalai M; Gordon D; Clare-Salzler MJ
Diabetes; 2007 Aug; 56(8):2116-23. PubMed ID: 17496235
[TBL] [Abstract][Full Text] [Related]
17. [Immunosuppression with cyclosporin induces clinical remission and improved beta cell function in patients with newly diagnosed insulin-dependent diabetes. A national and international multicenter study].
Mandrup-Poulsen TR; Mølvig JC; Andersen V; Bendtzen K; Binder C; Brøns M; d'Amore FA; Dieperink H; Enk B; Frandsen NE
Ugeskr Laeger; 1990 Jul; 152(27):1963-9. PubMed ID: 2195734
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D in diabetes mellitus-a new field of knowledge poised for D-velopment.
Alfonso B; Liao E; Busta A; Poretsky L
Diabetes Metab Res Rev; 2009 Jul; 25(5):417-9. PubMed ID: 19565622
[TBL] [Abstract][Full Text] [Related]
19. Interaction between pro-inflammatory and anti-inflammatory cytokines in insulin-producing cells.
Souza KL; Gurgul-Convey E; Elsner M; Lenzen S
J Endocrinol; 2008 Apr; 197(1):139-50. PubMed ID: 18372240
[TBL] [Abstract][Full Text] [Related]
20. High T-helper-1 cytokines but low T-helper-3 cytokines, inflammatory cytokines and chemokines in children with high risk of developing type 1 diabetes.
Stechova K; Bohmova K; Vrabelova Z; Sepa A; Stadlerova G; Zacharovova K; Faresjö M
Diabetes Metab Res Rev; 2007 Sep; 23(6):462-71. PubMed ID: 17315139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]